the aid library

LIST OPTIONS

Filter

12071

Financing Maternal and Child Health—What Are the Limitations in Estimating Donor Flows and Resource Needs?

Schäferhoff, M.; Schrade, C.; Yamey G. PLOS Med (2010) CC

Marco Schäferhoff and colleagues critique funding estimates for the maternal and child health Millennium Development Goals, and make recommendations for improving the tracking of financing flows and estimating the costs of scaling up interventions for mothers and children.

External Link

Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea

Marks, M.; O. Mitja; C. Bottomley, et al. (2018) CC

n this study, low-dose azithromycin did not meet the prespecified non-inferiority margin compared with standard-dose azithromycin in achieving clinical and serological cure in PCR-confirmed active yaws. Only a single participant (with presumed latent yaws) had definitive serological failure. This wo... more

External Link

Integrated community-based intervention for urinary schistosomiasis and soil-transmitted helminthiasis in children from Caxito, Angola

Lemosa, M.; Fançonya, C.; Moura, S. et al The royal society of tropical medicine and hygiene (2020) C2

Schistosomiasis and soil-transmitted helminths (STH) infections are major public health problems. We aimed to study the 6-mo impact of mass drug administration with praziquantel and albendazole on urinary schistosomiasis and STH.We examined children (aged 2–15 y) from one hamlet, who provided urin... more

External Link

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases

Brindha, J.; Balamurali, M.; Kaushik, C. Frontiers in Chemistry (2021) C1

Front Chem. 2021; 9: 622286. Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286

External Link

The use of low-cost Android tablets to train community health workers in Mukono, Uganda, in the recognition, treatment and prevention of pneumonia in children under five: a pilot randomised controlled

J.O’Donovan, K. Kabali, C. Taylor, et al. (2018) CC

Human Resources for Health201816:49; https://doi.org/10.1186/s12960-018-0315-7

Download (125)

View PDF (186)

Factors associated with HIV counseling and testing behavior among undergraduates of universities and vocational technical training schools in Tbilisi, Georgia

M. Djibuti; T. Zurashvili; T. Kasrashvili; C. J. Berg BMC Public Health (BioMed Central) (2015) CC

Djibuti et al. BMC Public Health (2015) 15:427 DOI 10.1186/s12889-015-1760-z

External Link

Countdown Global Mental Health 2030

Saxena, S.; D. Kestel, C. Sunkel, et al. (2019) CC

Lancet, Published:February 21, 2019DOI:https://doi.org/10.1016/S0140-6736(19)30424-6. This article announce the establishment of Countdown Global Mental Health, an independent, multistakeholder monitoring and accountability collaboration for mental health, within an initial timeframe of the UN Sust... more

Download (214)

View PDF (342)

The clinical examination of children, adolescents and their families

T. Lempp; D.de Lange; D. Radeloff; C. Bachmann IACAPAP (2012) C2

Introduction Chapter A.5

External Link

A practical clinical definition of epilepsy

R. S. Fisher; C. Acevedo; A. Arzimanoglou; et al. (2014) CC

Epilepsia, 55(4):475–482, 2014 doi: 10.1111/epi.12550

External Link

Tuberkulosescreening bei Schwangeren im Kontext von § 36 (4) Infektionsschutzgesetz (IfSG)

K. Schenkel, T. Bauer; C. Breuer; et al. (2016) C2

Eine Stellungnahme des DZK in Zusammenarbeit mit FZB, DGI, DGPI, GPP, DGGG, DRG und DGMP Pneumologie 2016; 70: 777–780

Download (77)

View PDF (67)

Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study

Asher, I.; Rutter, C.E.; Bissell, K. et al. The Lancet (2021) CC

Asthma is the most common chronic disease in children globally. The Global Asthma Network (GAN) Phase I study aimed to determine if the worldwide burden of asthma symptoms is changing. This updated cross-sectional study used the same methods as the International study of Asthma and Allergies in Chi...ldhood (ISAAC) Phase III. Asthma symptoms were assessed from centres that completed GAN Phase I and ISAAC Phase I (1993–95), ISAAC Phase III (2001–03), or both. We included individuals from two age groups (children aged 6–7 years and adolescents aged 13–14 years) who self-completed written questionnaires at school. We estimated the 10-year rate of change in prevalence of current wheeze, severe asthma symptoms, ever having asthma, exercise wheeze, and night cough (defined by core questions in the questionnaire) for each centre, and we estimated trends across world regions and income levels using mixed-effects linear regression models with region and country income level as confounders. Overall, 119 795 participants from 27 centres in 14 countries were included: 74 361 adolescents (response rate 90%) and 45 434 children (response rate 79%). About one in ten individuals of both age groups had wheeze in the preceding year, of whom almost half had severe symptoms. Most centres showed a change in prevalence of 2 SE or more between ISAAC Phase III to GAN Phase I. Over the 27-year period (1993–2020), adolescents showed a significant decrease in percentage point prevalence per decade in severe asthma symptoms (–0·37, 95% CI –0·69 to –0·04) and an increase in ever having asthma (1·25, 0·67 to 1·83) and night cough (4·25, 3·06 to 5·44), which was also found in children (3·21, 1·80 to 4·62). The prevalence of current wheeze decreased in low-income countries (–1·37, –2·47 to –0·27], in children and –1·67, –2·70 to –0·64, in adolescents) and increased in lower-middle-income countries (1·99, 0·33 to 3·66, in children and 1·69, 0·13 to 3·25, in adolescents), but it was stable in upper-middle-income and high-income countries. Trends in prevalence and severity of asthma symptoms over the past three decades varied by age group, country income, region, and centre. The high worldwide burden of severe asthma symptoms would be mitigated by enabling access to effective therapies for asthma. more

Download (392)

View PDF (1617)

Shock-Responsive Social Protection Systems research: Case study—Lesotho

Kardan, A., O’Brien, C. and Masasa, M. Oxford Policy Management (2017) C2

Download (240)

View PDF (261)

S3 – LEITLINIE: Posttraumatische Belastungsstörung (ICD-10: F43.1)

Flatten, G., Gast, U., Hofmann, A., Knaevelsrud, C., Lampe, A., Lieberman, P., Maercker, A., Reddemann, L. & Wöller, W. Trauma & Gewalt (2011) C2

TRAUMA & GEWALT 5. Jahrgang Heft 3/2011

Download (71)

View PDF (66)

Control and elimination of Schistosoma mansoni infection in adult individuals on Ukerewe island, northwestern Tanzania: baseline results before implementation of intervention measures

Mazigo, H.D.; Chiombola, C.E., S. Mugassa, et al. (2024) CC

BMC Infectious Diseases (2024) 24:1102 Communities living along the shoreline and on the islands of Lake Victoria in northwestern Tanzania remain endemic for schistosomiasis and suffer from the life-threatening morbidities associated with the disease.

Download (236)

View PDF (315)

Trends in Neonatal Mortality in Rwanda, 2000-2010

Winter, Rebecca, Thomas Pullum, Anne Langston, Ndicunguye V. Mivumbi, Pierre C. Rutayisire, Dieudonne N. Muhoza, and Solange Hakiba Calverton, Maryland, USA: ICF International. (2013) C2

DHS Further Analysis Reports No. 88 - This further analysis examines levels, trends, and determinants of neonatal mortality in Rwanda, using data from the 2000, 2005, and 2010 Rwanda Demographic and Health Surveys (RDHS).

External Link

Cervicovaginal Immune Activation in Zambian Women With Female Genital Schistosomiasis

Sturt, A.; Webb, E.; Patterson, C.; et al. Frontiers Media S.A. (2021) CC

Front. Immunol. 12:620657. doi: 10.3389/fimmu.2021.620657. HIV-1 infection disproportionately affects women in sub-Saharan Africa, where areas of high HIV-1 prevalence and Schistosoma haematobium endemicity largely overlap. Female genital schistosomiasis (FGS), caused most frequently by S. haemato... more

Download (90)

View PDF (74)

Measurement properties and interpretation of three shortened versions of the asthma control questionnaire

Juniper, E. F.; Svensson, K.; Mörk, A-C.; et al. Respiratory Medicine (2005) 99, 553–558 (2005) CC2

The Asthma Control Questionnaire (ACQ)1 was developed and validated to measure the primary clinical goal of asthma management as identified by international guidelines. They indicate that to achieve good control, treatment should minimise day and night time symptoms, activity limitation, airway narr... more

External Link

Access to Cancer Therapeutics in Low- and Middle-Income Countries

Ruff, P.; Sana-Al-Sukhun, C. Blanchard, et al. (2016) C2

2016 ASCO EDUCATIONAL BOOK | asco.org/edbo

Download (121)

View PDF (67)

Chronic obstructive pulmonary disease in sub-Saharan Africa

Awokola, B.I.; Amusa, G.A.; Jewell, C.P.; et al. International Journal of Tuberculosis and Lung Disease (2022) CC2

The article provides a systematic review and meta-analysis of the prevalence and risk factors of chronic obstructive pulmonary disease (COPD) in sub-Saharan Africa (SSA). It highlights that COPD is a significant cause of morbidity and mortality in the region, with prevalence rates ranging from 1.7% ... more

External Link (160)

Global burden of cardiovascular diseases and risks, 1990-2022

Mensah, G.A.; Fuster, V.; Murray, C.J.L. et al. Journal of the American College of Cardiology (2023) CC

Age-standardized cardiovascular disease (CVD) mortality rates by region ranged from 73.6 per 100,000 in High-income Asia Pacific to 432.3 per 100,000 in Eastern Europe in 2022. Global CVD mortality decreased by 34.9% from 1990 to 2022. Ischemic heart disease had the highest global age-standardized D... more